AI Newsletter

Polymarket values the probability of an Anthropic IPO by September 2026 at 88%, with market capitalization at launch potentially reaching $1.8 trillion according to prediction markets. Meanwhile, Anthropic is already dominating 8 of the Fortune 10 companies as customers with Claude, while Claude Opus 4.8 is aggressively targeting market share through price cuts. The IPO would for the first time bring reliable figures into the valuation debate and recalibrate the entire AI sector on the stock market.

Gartner predicts global AI spending of $2.6 trillion for 2026 – a 47% increase from the previous year, driven by the shift from pilot projects to productive deployments. At the center is Agentic AI: systems autonomously take over supply chain management, demand sensing, and operations – CFOs demand measurable ROI instead of experiments. Companies like Novo Nordisk, Netflix, and Salesforce are already using AI agents productively, which massively increases pressure on laggards.

Meta has unveiled an AI agent specifically designed for enterprise operations to automate everyday business processes – a direct attack on OpenAI, Anthropic, and Microsoft Copilot in the lucrative enterprise segment. The move marks Meta's strategic reorientation from consumer to B2B market and intensifies competition significantly. With Meta's reach and infrastructure, this could substantially shift price dynamics in the enterprise AI market.

Mistral AI has completed a clear positioning as a sovereign alternative to US providers with the launch of 'Vibe' and industrial partnerships with Airbus and BMW, and announces its own data center expansion. The strategy targets regulation-intensive sectors such as aerospace, banking, and government agencies, where data sovereignty is critical. In parallel, Mistral acquired an AI startup within a week – part of a coordinated consolidation wave in which Anthropic, Google DeepMind, and Meta each also made an acquisition.

President Trump signed an Executive Order on AI security establishing a framework for government pre-review of frontier models – Polymarket sees a 60% probability of a formal Federal Review by end of June. According to Politico, the order aims to review models similar to how the FDA reviews pharmaceuticals, which could significantly slow release cycles. This creates potential market access barriers to the US for international AI companies, while US labs must factor in regulatory lead times.